AtaiBeckley (ATAI) Revenue (2021 - 2026)

AtaiBeckley (ATAI) reported Revenue of $749000.0 for Q3 2025, up 1772.5% on a YoY basis from $40000.0 in Q3 2024, and up 4.17% sequentially from $719000.0 in Q2 2025.

AtaiBeckley (ATAI) Revenue (2021 - 2026) Analysis & Trends

AtaiBeckley (ATAI) has 5 years of Revenue data on file, last reported at $749000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 1772.5% year-over-year to $749000.0; the trailing twelve-month figure through Sep 2025 stood at $3.0 million (up 816.92% YoY), and the FY2024 full-year result was $308000.0, down 1.91% from the prior year.
  • Revenue slipped to $954000.0 in Q1 2026 per ATAI's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Revenue topped out at $1.6 million in Q1 2025 and bottomed at $12000.0 in Q4 2024.
  • The 3-year median for Revenue is $954000.0 (2026), against an average of $840333.3.
  • Across the five-year window, Revenue plunged 90.98% in 2022 and surged 1772.5% in 2025, its largest moves.
  • Year by year, Revenue stood at $12000.0 in 2024, then jumped by 12858.33% to $1.6 million in 2025, then sank by 38.65% to $954000.0 in 2026.
  • Per Business Quant, the three latest ATAI Revenue figures stand at $954000.0 (Q1 2026), $1.6 million (Q1 2025), and $12000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 AtaiBeckley 2.56 Bn 2.56 Bn - 749,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 954,000.00
Sep 30, 2025 749,000.00
Jun 30, 2025 719,000.00
Mar 31, 2025 1.56 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 12,000.00
Dec 31, 2024 12,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 273,000.00
Dec 31, 2023 18,000.00
Sep 30, 2023 87,000.00
Jun 30, 2023 172,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 24,000.00
Jun 30, 2022 170,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 266,000.00
Mar 31, 2021 19.88 Mn